Month: March 2022

WILMINGTON, Del., March 07, 2022 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) today announced a new program called Responsible Solvers™ that brings together the  company’s global philanthropic commitment to science, technology, engineering, and math (STEM) education, with additional STEM funding and a paid employee volunteer program. Closely aligned with the company purpose to Responsibly solve for a better world, the Responsible Solvers™ program is designed to put the power of Ashland people and products in the hands of the communities where employees work, live and play.  “The increased funding is not just a philanthropic investment,” said Guillermo Novo, chair and chief executive officer, Ashland. “It is a strategic part of our business model. Ashland’s transformation shows why leading on environment, social and...

With a strategic focus on environmental diagnostics and modelling, the investment in ESI is part of an initiative to improve urban livability and sustainability TORONTO, March 07, 2022 (GLOBE NEWSWIRE) — IBI Group (TSX: IBG) announced today it has taken a minor equity position in Ecosystem Informatics Inc. (ESI), a private company specializing in environmental monitoring, diagnostics and pollution abatement solutions designed to help clients protect the environment and enhance business performance. Similar to IBI Group’s investment in SWTCH, an electric vehicle charging and energy management solutions provider, this investment is reflective of the firm’s commitment to taking action against climate change and improving the environment. The partnership will enable ESI to expand its reach to urban municipalities and businesses around...

TDC and DKT Holdings releases its financial calendar for 2022 as set out below. 8 April Start of closed period prior to Interim Financial Statements January – March 2022 28 April Annual Report 2021 public on www.tdcgroup.com 6 May Interim Financial Statements January – March 2022 8 July Start of closed period prior to Interim Financial Statements January – June 2022 12 August Interim Financial Statements January – June 2022 10 October Start of closed period prior to Interim Financial Statements January – September 2022 9 NovemberInterim Financial Statements January – September 2022 31 DecemberEnd of fiscal year 2022 Release of financial statements for the year and interim financial statements is expected at approximately 9:00 am (CET) on the days referred to. The closed trading window for persons employed by the TDC Group is 30 days prior...

HONG KONG, March 07, 2022 (GLOBE NEWSWIRE) — Graphex Group Limited (“Graphex”) (OTCQX: GRFXY | HKSE: 6128), has publicly filed a registration statement on Form F-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) relating to its proposed public offering (“Offering”) of American Depositary Shares (“ADS”). The Offering will raise additional capital to Graphex which will be used, primarily, to expand its graphene business to support global demand. The number of ADS to be offered and the price range for the proposed offering have not yet been determined. Graphex will apply to list the receipts representing the ADS on the NYSE American stock exchange market under the symbol “GRFX” and expects to have the listing complete concurrent with the closing...

ANN ARBOR, Mich., March 07, 2022 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announced significant advancements in its Vietnam based production facility, Prodigy Textiles. The collaboration between the Company’s US and Vietnam lab teams has resulted in their first complete genetic screening of in-process production silkworms. This fifth generation of silkworms, now being reared in Vietnam, is the first production cycle of silkworms at the factory to receive 100% genetic screening. This level of testing, for Kraig Labs, was previously only available at the Company’s R&D headquarters is now being fully transferred to the Vietnamese lab team. Earlier...

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) — Verizon Communications Inc. (“Verizon”) (NYSE, NASDAQ: VZ) today announced that, in connection with the Offers (as defined below), all Notes (as defined below) validly tendered and not validly withdrawn at or prior to the Early Participation Date (as defined below) will be accepted for purchase, in accordance with the terms of the Offer to Purchase (as defined below). As a result, the Waterfall Cap (as defined below) will be increased from a total cash amount of up to $4.0 billion to a total cash amount sufficient to accept for purchase all notes tendered prior to the Early Participation Date (approximately $5.6 billion). Verizon also announced the early participation results, as of 5:00 p.m. (Eastern time) on March 4, 2022 (the “Early Participation Date”), of its previously announced...

HOUSTON, March 07, 2022 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, announced that Gail McIntyre, Ph.D., DABT, Chief Executive Officer of Aravive, will participate in an in-person fireside chat at the 34th Annual ROTH Conference on Monday, March 14, 2022, at 8:30 am PT in HEALTHCARE VFC – Suite 2022 at The Ritz Carlton, Dana Point, California. Dr. McIntyre and Vinay Shah, Chief Financial Officer of Aravive, will be available for one-on-one meetings on Monday, March 14th. A live webcast and a replay of the presentation will be available on Events & Presentations page of www.aravive.com. About AraviveAravive, Inc. is a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease. Our...

The parties have entered into a collaboration agreement to develop Targovax´s TG mutant KRAS cancer vaccines in combination with Agenus´s QS-21 STIMULON adjuvant technology The agreement may be extended into an exclusive commercial partnership for KRAS vaccination if the combination proves effective in exploratory clinical studiesLEXINGTON, Mass., March 07, 2022 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activate immune response to cancers and infections, and Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announce that they have entered into a clinical collaboration and supply agreement to combine Targovax’s TG mutant KRAS...

WATERTOWN, Mass., March 07, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced the appointment of Isabelle Lefebvre as Chief Regulatory Officer. Ms. Lefebvre brings over 30 years of global regulatory affairs experience across all phases of drug development including ophthalmic and ocular conditions. Ms. Lefebvre is succeeding John Weet, Ph.D., who be leaving his role as Senior Vice President, Regulatory, following a transition period. “Isabelle brings a wealth of regulatory strategy experience from large and midsize global pharmaceutical companies along with a strong track record of leading successful drug approvals in the ocular space, and we are...

Builders FirstSource Hires Amy Bass Messersmith as Chief People Officer Amy Bass Messersmith, Chief People Officer, Builders FirstSourceDALLAS, March 07, 2022 (GLOBE NEWSWIRE) — Builders FirstSource, Inc. (NYSE: BLDR) (“Builders FirstSource”), today announced that Amy Bass Messersmith will be joining Builders FirstSource as its Chief People Officer, effective March 14, 2022. In this role, Ms. Messersmith will be a member of the Builders FirstSource executive leadership team, overseeing all aspects of human resources, including the implementation of strategies to develop and promote best practices in organizational and leadership development, diversity and inclusion, and talent acquisition, development, and management. “We are excited to bring Ms. Messersmith on as Chief People Officer, and I am confident that her strong and...